• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Biosystems International

edit

BioSystems International (BSI) brings biomarkers to the bedside. They improve pharmaceutical drug discovery and development productivity, i.e. safer and more effective drugs at lower costs and in less time. BSI delivers tools for disease management.

Recent Milestones

edit

• 
  Biosystems International received $2.7M in Series C funding. (7/19/10)
  Posted 11/3/10 at 10:48pm via biosys-intl.com
• 
  Biosystems International received $4.6M in Venture Round funding. (10/29/08)
  Posted 6/17/09 at 11:03pm via reuters.com
• 
  Biosystems International was acquired by DL Software. (1/16/08)
  Posted 9/21/09 at 6:05pm
• 
  Biosystems International received $3.89M (€3M) in Seed funding. (4/1/05)
  Posted 8/31/10 at 3:19am via biosys-intl.com
• 
  Biosystems International added Jean Pierre TIROUFLET as CEO.
  Posted 6/17/09 at 10:47pm
• 
  Biosystems International added Laszlo TAKACS as Founder, CSO, General Director.
  Posted 6/17/09 at 10:47pm
• 
  Biosystems International added András GUTTMAN as Founder, CTO.
  Posted 6/17/09 at 10:47pm

Videos

Screenshots

edit

Above: Biosystems International
Uploaded: 6/18/09

Sources

1. Citation Needed [add]
2. BSI FUNDING (biosys-intl.com) [edit]
3. Biosystems International raises $ 4.6 Million Venture Capital for New Diagnostics in Cancer (reuters.com) [edit]
4. Biosystems International raises € 2.1 Million to support development of lung cancer blood test (biosys-intl.com) [edit]